AI replacing animal experiments? A message from the FDA has left "monkey breeders" feeling devastated, and experts state that "we are still far from the stage of implementation."
① The news that the USA FDA has publicly stated it will gradually replace animal testing requirements has led to an increase in the stock prices of AI pharmaceutical companies, impacting traditional drug evaluation CRO companies; ② Some believe this action represents a trend in Industry development. However, others believe that it is far from being implementable.
Express News | Harrow Inc - Klarity-C Patients to Access Vevye for $59 per Bottle
B.Riley Financial Maintains Harrow(HROW.US) With Buy Rating, Cuts Target Price to $65
Harrow Is Maintained at Buy by B. Riley Securities
Harrow Price Target Cut to $65.00/Share From $69.00 by B. Riley Securities
H.C. Wainwright Maintains Harrow(HROW.US) With Buy Rating, Maintains Target Price $57
Sundancer28 : WOW!! Truly perfection! Good for you
🩷